[Drug-induced leukoencephalopathy].
Mizutani
Tomohiko
T
Division of Neurology, Department of Medicine, Nihon University School of Medicine.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000998:Antiviral Agents / Q000009:adverse effects; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016898:Interferon-alpha / Q000008:administration & dosage; D008727:Methotrexate / Q000009:adverse effects; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D013997:Time Factors
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D016898:Interferon-alpha; C017367:carmofur; D005472:Fluorouracil; D008727:Methotrexate